CoreAge Rx vs He & She MD
Both open at $99 by injection across fifty states, and they diverge on catalog depth.
Disclosure: Buy This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
CoreAge Rx
Partner
$99/mo
Semaglutide is $99 a month and tirzepatide $149, both injectable, with no oral line. Fifty states. These figures were last checked on 5 August 2026, earlier than the rest of this group, so treat them as the oldest reading here.
Pick it for: Buyers who want the decision reduced to two numbers
He & She MD
Editorial
$99/mo
Terms paid up front rather than a rolling monthly charge: injectable semaglutide advertises $99 a month against a struck $199 and bills $1,188 for the year, while injectable tirzepatide bills $1,908. The oral line is $199 a month for six months and then renews at $1,434 per six months, a figure carried in a footnote rather than on the card.
Pick it for: Buyers who want a third option priced before enrolling
Our verdict
CoreAge Rx sells two products and nothing else; He and She MD carries a third priced line. Neither states what the figure does as the dose rises.
Before you choose either
Ask both sellers what dose the monthly price buys before you compare the two figures. A price is only a price once you know what quantity it is attached to, and a seller that will not answer has told you something. Set both against every published price we hold rather than against each other alone.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.